Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years of age and above, and Cotempla XR-ODT for patients from six to seventeen years old. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado. more
Time Frame | AYTU | Sector | S&P500 |
---|---|---|---|
1-Week Return | -4.17% | -2.12% | -2.22% |
1-Month Return | -7.38% | -3.42% | 0.07% |
3-Month Return | -43.67% | -11.13% | 3.71% |
6-Month Return | -50.71% | -5.74% | 8.04% |
1-Year Return | -51.75% | 3.97% | 26.32% |
3-Year Return | -95.61% | 1.05% | 29.42% |
5-Year Return | -99.19% | 34.37% | 83.36% |
10-Year Return | -100% | 97.88% | 185.56% |
Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 27.63M | 65.63M | 96.67M | 107.40M | 81.00M | [{"date":"2020-06-30","value":25.73,"profit":true},{"date":"2021-06-30","value":61.11,"profit":true},{"date":"2022-06-30","value":90.01,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":75.42,"profit":true}] |
Cost of Revenue | 7.55M | 36.43M | 44.39M | 40.77M | 26.42M | [{"date":"2020-06-30","value":17.02,"profit":true},{"date":"2021-06-30","value":82.08,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":91.85,"profit":true},{"date":"2024-06-30","value":59.51,"profit":true}] |
Gross Profit | 20.08M | 29.20M | 52.28M | 66.63M | 54.59M | [{"date":"2020-06-30","value":30.13,"profit":true},{"date":"2021-06-30","value":43.82,"profit":true},{"date":"2022-06-30","value":78.47,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":81.92,"profit":true}] |
Gross Margin | 72.67% | 44.49% | 54.08% | 62.04% | 67.39% | [{"date":"2020-06-30","value":100,"profit":true},{"date":"2021-06-30","value":61.23,"profit":true},{"date":"2022-06-30","value":74.43,"profit":true},{"date":"2023-06-30","value":85.38,"profit":true},{"date":"2024-06-30","value":92.74,"profit":true}] |
Operating Expenses | 41.01M | 67.44M | 88.39M | 78.96M | 60.57M | [{"date":"2020-06-30","value":46.4,"profit":true},{"date":"2021-06-30","value":76.3,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":89.34,"profit":true},{"date":"2024-06-30","value":68.53,"profit":true}] |
Operating Income | (20.94M) | (38.24M) | 37.22M | (17.07M) | (5.25M) | [{"date":"2020-06-30","value":-56.25,"profit":false},{"date":"2021-06-30","value":-102.75,"profit":false},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":-45.86,"profit":false},{"date":"2024-06-30","value":-14.12,"profit":false}] |
Total Non-Operating Income/Expense | - | - | - | (4.95M) | (13.61M) | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":-494900000,"profit":false},{"date":"2024-06-30","value":-1361400000,"profit":false}] |
Pre-Tax Income | (13.62M) | (58.03M) | (110.28M) | (17.05M) | (14.08M) | [{"date":"2020-06-30","value":-1362067900,"profit":false},{"date":"2021-06-30","value":-5803000000,"profit":false},{"date":"2022-06-30","value":-11028300000,"profit":false},{"date":"2023-06-30","value":-1705100000,"profit":false},{"date":"2024-06-30","value":-1407600000,"profit":false}] |
Income Taxes | (9.92M) | 259.00K | (110.00K) | (57.00K) | 1.77M | [{"date":"2020-06-30","value":-561.15,"profit":false},{"date":"2021-06-30","value":14.65,"profit":true},{"date":"2022-06-30","value":-6.22,"profit":false},{"date":"2023-06-30","value":-3.22,"profit":false},{"date":"2024-06-30","value":100,"profit":true}] |
Income After Taxes | - | - | - | (16.99M) | (15.84M) | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":-1699400000,"profit":false},{"date":"2024-06-30","value":-1584400000,"profit":false}] |
Income From Continuous Operations | (13.62M) | (58.29M) | (110.17M) | (17.05M) | (15.84M) | [{"date":"2020-06-30","value":-1362067900,"profit":false},{"date":"2021-06-30","value":-5828900000,"profit":false},{"date":"2022-06-30","value":-11017300000,"profit":false},{"date":"2023-06-30","value":-1705100000,"profit":false},{"date":"2024-06-30","value":-1584400000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Net Income | (3.70M) | (58.29M) | (108.78M) | (17.05M) | (15.84M) | [{"date":"2020-06-30","value":-369960300,"profit":false},{"date":"2021-06-30","value":-5828900000,"profit":false},{"date":"2022-06-30","value":-10878000000,"profit":false},{"date":"2023-06-30","value":-1705000000,"profit":false},{"date":"2024-06-30","value":-1584400000,"profit":false}] |
EPS (Diluted) | (96.20) | (65.20) | (76.20) | (5.03) | (2.86) | [{"date":"2020-06-30","value":-9620,"profit":false},{"date":"2021-06-30","value":-6520,"profit":false},{"date":"2022-06-30","value":-7620,"profit":false},{"date":"2023-06-30","value":-503,"profit":false},{"date":"2024-06-30","value":-286,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
AYTU | |
---|---|
Cash Ratio | 0.33 |
Current Ratio | 0.99 |
Quick Ratio | 0.80 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
AYTU | |
---|---|
ROA (LTM) | -1.06% |
ROE (LTM) | -47.24% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
AYTU | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.74 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.26 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
AYTU | |
---|---|
Trailing PE | NM |
Forward PE | 2.32 |
P/S (TTM) | 0.10 |
P/B | 0.29 |
Price/FCF | NM |
EV/R | 0.06 |
EV/Ebitda | 0.69 |
PEG | NM |
Aytu BioScience Inc (AYTU) share price today is $1.414
Yes, Indians can buy shares of Aytu BioScience Inc (AYTU) on Vested. To buy Aytu BioScience Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AYTU stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Aytu BioScience Inc (AYTU) via the Vested app. You can start investing in Aytu BioScience Inc (AYTU) with a minimum investment of $1.
You can invest in shares of Aytu BioScience Inc (AYTU) via Vested in three simple steps:
The 52-week high price of Aytu BioScience Inc (AYTU) is $3.45. The 52-week low price of Aytu BioScience Inc (AYTU) is $1.3.
The price-to-earnings (P/E) ratio of Aytu BioScience Inc (AYTU) is
The price-to-book (P/B) ratio of Aytu BioScience Inc (AYTU) is 0.29
The dividend yield of Aytu BioScience Inc (AYTU) is 0.00%
The market capitalization of Aytu BioScience Inc (AYTU) is $8.49M
The stock symbol (or ticker) of Aytu BioScience Inc is AYTU